HARNESSING THE REGENERATIVE POWER OF THE BODY®

Human Regenerative Technologies, LLC (HRT®) is a leading biologics company, focused on advancing the understanding and development of human allograft tissue products through scientific analysis and clinical application.


ADVANCED HYDRATEK® PROCESS

Extensive product variety

INNOVATIVE INDUSTRY LEADERS

THE HYDRATEK® PROCESS


 
 

HRT®’s advanced HydraTek® process has produced an extensive product offering, including a variety of membrane products, a Cryo-preserved connective tissue matrix and the world’s first ambient temperature, connective tissue matrix allograft. This patent-pending formulation is the only one of its kind in market, and offers physicians and facilities an off-the-shelf, ready-to-use connective tissue matrix for homologous use.

HydraTek® allografts are not compromised by the industry’s standard drying methods, which may lead to protein denaturing and collagen collapse.

HydraTek® flowable grafts are uniquely processed to preserve the natural structure and biological integrity, providing the connective tissue matrix in its natural consistency for improved delivery and performance.

HydraTek® membrane allografts have optimally reduced hydration levels to provide ideal graft handling, strength and performance.


GROWTH FACTORS PRESERVED BY the HYDRATEK® PROCESS

 

SCAFFOLD COMPONENTS in placental tissues

Untitled-1-01.png

MMP INHIBITORS

MMPIcons-01-01.png
 

ANTI-INFLAMMATORIES

FLOWABLE CONNECTIVE TISSUE MATRIX


 
 
 

TWO CONNECTIVE TISSUE Matrix OPTIONS

HRT®’s advanced HydraTek® Process produces an industry-leading product offering, including a unique cryopreserved connective tissue matrix, and the world’s first ambient temperature connective tissue matrix allografts.

A True Fluid Graft – Maintains the native fluid consistency of the placental tissue matrix. Not just a ‘powder’ or ‘particulate’

A Complete Tissue Matrix – Provides the complete range of beneficial tissue matrix components. Not just a ‘morselized membrane’

 

Cryo Version

Ambient Version

Natural Fluid Graft

Ready to Use

5 yr Shelf Life


biologic content vs competitors

 

THE RIGHT CHOICE EVERY TIME

 

MEMBRANE TISSUE PRODUCTS 


 
 

TWO MEMBRANE TISSUE THICKNESSES

HRT®’s advanced HydraTek® Technology has produced an extensive membrane product offering, including a variety of advanced membrane tissue options in various thicknesses and configurations. The HydraTek® process offers:

A Complete Line of Amnion Only Membranes

Chorion Based Options


webtemp.png

Room Temp

Easy to Cut

Apply Dry or Wet

InjectIcon.png

Easily Applied

Five-02.png

5 yr Shelf Life


BENEFITS OF PLACENTAL TISSUE


membrane.img.AC4548.2.jpg
 
 

Amniotic and placental tissues are a rich natural source of human ExtraCellular Matrix (ECM) and connective tissue components. The ECM contains a protein system that provides the foundation for the body’s tissues and organs.[1,2] The placental ECM is unique, in that its young, viable proteins have not deteriorated throughout the life cycle of the body.


Physical Covering
Amniotic membranes provide an ideal human tissue membrane that covers, protects, and provides natural gliding capabilities between tissues.[3,4]

Natural Source of Growth Factors
Growth factors contained in the ECM include PDGF, VEGF, EGF, FGF and TGF-B.[8]

Scaffold Components
The ECM also contains Collagens I, III, IV, V, VI, VII, fibrous proteins that provide a structural scaffold.[5,6] Fibronectin, integrins, laminins, and hyaluronans also play a key role in adherence to the scaffold.[7-9]

list4-01-01.png

Naturally Anti-Inflammatory
Amniotic membranes are shown to contain naturally anti-inflammatory properties, which may limit the risk of fibrous tissue growth and potential scar tissue formation.[11,12]

Non-Immunogenic
Amniotic membranes are ‘immune-privileged’, possessing little or no risk of foreign body reaction, which can lead to fibrosis and graft failure.[13]

Anti-Microbial
Application of amniotic membrane as a wound covering has been shown to reduce bacteria counts in the wound, demonstrated against a wide range of bacteria.[14]

 

1-14 Data on file.

INNOVATIVE INDUSTRY LEADERS


1-2.jpg
 
regerg.png
 

Human Regenerative Technologies, LLC (HRT®) is a biologics company focused on advancing the understanding and development of human amniotic and placental properties through scientific and clinical application.


HRT®’s product development team has over 50 years combined biologics experience. Our team’s research and development has enabled HRT® to emerge as a leader in natural human tissue allografts derived from amniotic membranes and placental connective tissues.

HRT® continues to advance biologic technologies derived from the dynamic placental system, which provides the foundation of the body’s various tissues and organs.

HRT® is proud to be accredited by the American Association of Tissue Banks® (AATB).